Literature DB >> 27236773

Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness.

Mohamed Abo El-Asrar1, Nancy Samir Elbarbary2, Eman Abdel Rahman Ismail3, AlShaimaa Abo Bakr1.   

Abstract

BACKGROUND: Angiopoietin-2 is a growth factor involved in the pathophysiology of vascular and inflammatory diseases such as arteriosclerosis. Carotid or aortic scans provide noninvasive screening tools for assessment of preclinical atherosclerosis in high-risk children. AIM: We assessed serum angiopoietin-2 in children and adolescents with type 1 diabetes mellitus as a potential marker for vascular complications in relation to glycemic control, inflammation and vascular structure.
METHODS: Sixty patients with type 1 diabetes were divided into 2 groups according to the presence of micro-vascular complications and compared with 30 healthy controls. High-sensitivity C-reactive protein (hs-CRP), hemoglobin A1c (HbA1c), urinary albumin/creatinine ratio, serum angiopoietin-2, carotid and aortic intima-media thickness (CIMT and AIMT) were measured.
RESULTS: CIMT, AIMT and serum angiopoietin-2 levels were significantly increased in patients with and without micro-vascular complications compared with controls, and the highest levels were in patients with complications (p < 0.001). Angiopoietin-2 was higher in patients with microalbuminuria than normoalbuminuric group (p < 0.001). Fasting blood glucose, HbA1c, hs-CRP, CIMT and AIMT were independently related to angiopoietin-2 in multiple regression analysis. Disease duration, hyperglycemia, poor glycemic control, hypercholesterolemia, inflammation and angiopoietin-2 were independent factors contributing to atherosclerosis risk.
CONCLUSION: The relation between angiopoietin-2 and assessed parameters of vascular structure in type 1 diabetes reflects a state of endothelial injury and highlights the role of disturbed angiogenesis and vascular inflammation in the occurrence of diabetic complications.

Entities:  

Keywords:  Angiopoietin-2; Aortic/carotid intima-media thickness; Atherosclerosis; Nephropathy; Type 1 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27236773     DOI: 10.1007/s10456-016-9517-6

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  6 in total

1.  Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression.

Authors:  Mona K Tawfik; Mohammed M Keshawy; Samy Makary
Journal:  Mol Biol Rep       Date:  2021-08-24       Impact factor: 2.316

Review 2.  Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?

Authors:  Evgenia Gourgari; Dana Dabelea; Kristina Rother
Journal:  Curr Diab Rep       Date:  2017-11-03       Impact factor: 4.810

Review 3.  The Impact of Diabetes Mellitus on Cardiovascular Risk Onset in Children and Adolescents.

Authors:  Ida Pastore; Andrea Mario Bolla; Laura Montefusco; Maria Elena Lunati; Antonio Rossi; Emma Assi; Gian Vincenzo Zuccotti; Paolo Fiorina
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

4.  Aortic intima media thickness in children and adolescents with type 1 diabetes: A systematic review.

Authors:  Megan L Gow; Benjamin J Varley; Reeja F Nasir; Michael R Skilton; Maria E Craig
Journal:  Pediatr Diabetes       Date:  2022-02-21       Impact factor: 3.409

5.  Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study.

Authors:  Xiaoxiao Yang; He Zhang; Yuanyuan Shi; Zanzhe Yu; Hao Yan; Zhaohui Ni; Jiaqi Qian; Wei Fang
Journal:  J Transl Med       Date:  2018-11-16       Impact factor: 5.531

6.  Osteopontin for Early Detection of Microvascular and Macrovascular Type 1 Diabetic Complication.

Authors:  Soha M Abd El Dayem; Abo El Magd El Bohy; Ahmed A Battah; Mona Hamed; Shereen Hamdy Abd El Aziz
Journal:  Open Access Maced J Med Sci       Date:  2019-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.